About Chempro Pharma
Chempro Pharma is a company based in Mumbai (India) founded in 2001 was acquired by Hextar Global in March 2021. Chempro Pharma offers products and services including APIs, Finished Formulations, Critical Raw Materials, Specialty Chemicals, and Healthcare Devices Distribution. Chempro Pharma operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Mumbai, India
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chempro Pharma Private Limited
- Date of Incorporation 17 May, 2008
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$5.03 M (USD)27.47as on Mar 31, 2024
-
Net Profit
$53.28 K (USD)-0.56as on Mar 31, 2024
-
EBITDA
-$29.04 K (USD)-126.05as on Mar 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Hextar Global
(Mar 08, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Chempro Pharma
Chempro Pharma offers a comprehensive portfolio of products and services, including APIs, Finished Formulations, Critical Raw Materials, Specialty Chemicals, and Healthcare Devices Distribution.
Manufacture and export of active pharmaceutical ingredients for drugs.
Production of ready-to-use drug formulations for global markets.
Supply of essential raw materials for pharmaceutical production.
Development and export of fine chemicals and dyes for industries.
Platform for distributing global healthcare devices in India.
Funding Insights of Chempro Pharma
Detailed funding history for Chempro Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Chempro Pharma
Chempro Pharma has secured backing from 1 investor. Prominent investors backing the company include Hextar Global.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment holding company distributing agrochemicals, energy solutions, and industrial products.
|
Locked | Locked | Locked |
Investor details for Chempro Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chempro Pharma
Investment portfolio details for Chempro Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chempro Pharma
Detailed financials for Chempro Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chempro Pharma Comparisons
Peer comparison for Chempro Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chempro Pharma
Chempro Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Chempro Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chempro Pharma
Complete news archive for Chempro Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chempro Pharma
Chempro Pharma was founded in 2001.
Chempro Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Arun Sehgal is the current CEO of Chempro Pharma.
Annual revenue of Chempro Pharma is $5.03M as on Mar 31, 2024.
Chempro Pharma was founded in 2001 in Mumbai, India, as a manufacturer of active pharmaceutical ingredients and formulations. Operations include production for the domestic market and exports to Japan, China, Indonesia, North America, Latin America, and the African sub-continent. Contract manufacturing services are provided to companies such as Pfizer, GlaxoSmithKline, Ranbaxy, Dr. Reddys, Abbott, Merck, and Novartis.
Chempro Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Chempro Pharma offers APIs, Finished Formulations, Critical Raw Materials, Specialty Chemicals, and Healthcare Devices Distribution.
Chempro Pharma has 1 investor. Key investors include Hextar Global.